After reviewing guidance for FY13 back in November, Hologic (HOLX) has decided to sell its...
After reviewing guidance for FY13 back in November, Hologic (HOLX) has decided to sell its Lifecodes business unit to Immucor (BLUD). Under the terms, HOLX will receive $85M in cash at closing and have the opportunity to earn a contingent payment of $10M based on achievement of certain financial targets throughout 2013. The transaction is expected to close during Q2.
Check out Seeking Alpha’s new Earnings Center »
From other sites
at Zacks.com (Thu, 9:51AM)
at Nasdaq.com (Mar 16, 2015)
at Zacks.com (Mar 6, 2015)
at Nasdaq.com (Jan 12, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs